New Mexico Immunization Program Website
HEPATITIS B PREVENTION
Perinatal Hepatitis B Prevention
The purpose of the Perinatal Hepatitis B Program is to prevent the transmission of the Hepatitis B virus (HBV) from mother to infant. This is performed by the identification of young women of childbearing age with positive Hepatitis B lab results then determining if they are pregnant, if so they are case managed throughout their pregnancy and delivery. The infant is then followed to ensure they receive the appropriate post-exposure prophylaxis, complete their hepatitis B vaccine series and have their blood serology drawn to determine their immune status.
In the United States, HBV infects about 80,000 each year, and 1.25 million people are chronically infected. As many as 90% of children infected perinatally will go on to develop chronic hepatitis B infection. About 5,000 Americans die each year from Hepatitis B and its related complications.
Infants are at very high risk of being infected with HBV when born to HBsAg positive mothers. Vertical transmission occurs from mother to baby during birth. Children who are not infected at birth remain at risk for horizontal transmission from interpersonal contact with their infected mothers or living in households with chronically infected persons through blood or exposure to infectious body fluids. Hepatitis B vaccine has been available since 1982 and is 95% effective in preventing HBV infection and its chronic consequences. It is the first vaccine against a major human cancer.
Key points of prevention:
The Hepatitis Program, NMDOH, offers free hepatitis A and B immunization to the following high risk adults:
For more information, or to find out if you qualify for free immunization, please call your local health office, or the New Mexico Hepatitis Hotline:
1-888-364-4372 or 1-888-DOH-HEPC .
Adobe Reader plug-in is needed to view documents on this web page.